Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational study

Supportive Care in Cancer

Volumn 11, Issue 3, 2003, Pages 156-161

  Fabi, Alessandra ^a   Barduagni, Mario ^a   Lauro, Salvatore ^b   Portalone, Luigi ^c   Mauri, Mariella ^g   Marinis, Filippo ^c   Narduzzi, Carla ^d   Tonini, Giuseppe ^e   Giampaolo, Marianna ^f   Pacetti, Umberto ^a   Paoloni, Francesca ^a   Cognetti, Francesco ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d SANDRO PERTINI HOSPITAL   (Italy)

^e Sanitary Direction Medical Board   (Italy)

^f Umberto I Hospital   (Italy)

^g NONE

Author keywords

Antiemetic treatment; Chemotherapy induced emesis; Delayed emesis

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CORTICOSTEROID; DEXAMETHASONE; ETOPOSIDE; GEMCITABINE; GRANISETRON; METOCLOPRAMIDE; NAVELBINE; ONDANSETRON; SEROTONIN 3 ANTAGONIST; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; CANCER CENTER; CHEMICALLY INDUCED DISORDER; EVALUATION; ITALY; LONGITUDINAL STUDY; MIDDLE AGED; NAUSEA; PROSPECTIVE STUDY; STANDARD; VOMITING;

ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CANCER CARE FACILITIES; FEMALE; HUMANS; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NAUSEA; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; VOMITING;

EID: 0037531290     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-002-0427-3     Document Type: Article

References (13)

1. Antiemetic Subcommitee of the Multinational Association of Supportive Care in Cancer (1998) Prevention of chemotherapy- and radiotherapy-induced emesis: results of the Perugia Consensus Conference. Ann Oncol 9:811-819
2. Johnston D, Latreille J, Laberge F, Stewart D, Rusthoven J, Findlay B, Ernst S, Williams CKO, Hoskins P, Yelle L, McMurtrie E, Dhaliwal H, Nishimura L, Pater J, Zee B (1995) Preventing nausea and vomiting during days 2-7 following high dose cisplatin chemotherapy (HDCP). A study by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). Proc Am Soc Clin Oncol 14:529
3. Kaizer L, Warr D, Hoskins P, Latreille J, Lofters W, Yau J, Palmer M, Zee B, Levy M, Pater J (1994) Effect of the schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderating emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:1050-1057
4. Kris MG, Gralla RJ, Clark RA, Tyson LB, O'Connel JP, Wertheim MS, Kelsen DP (1985) Incidence, cause, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J Clin Oncol 3:1379-1384
5. Kris MG, Roila F, De Mulder PHM, Marty M (1998) Delayed emesis following anticancer chemotherapy. Support Care Cancer 6:228-232
6. Louvet C, Lorange A, Letendre F, Beaulieu R, Pretty HM, Courchesne Y, Nemeh JA, Monte M, Latreille J (1991) Acute and delayed emesis after cisplatin-based regimen: description and prevention. Oncology 48:392-396
7. Navari RM, Reinhardt RR, Gralla RJ, Kris MG, Hesketh PJ, Khojasteh MD, Kindler H, Grote TH, Pendergrass K, Grunberg SM, Carides AD, Gertz BJ (1999) Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group. N Engl J Med 340:190-195
8. O'Brien MER, Cullen MH, Woodroffe C, Kelly K, Burman C, Palmer K, Stuart NS, Blackledge GR, Sharpe J (1989) The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial. Br J Cancer 60:759-763
9. Roila F, Boschetti E, Tonato M, Basurto C, Bracarda S, Picciafuoco M, Patoia L, Santi E, Penza O, Ballatori E (1991) Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study. Am J Clin Oncol 14:238-242
10. The Italian Group for Antiemetic Research (1995) Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 332:1-5
11. The Italian Group for Antiemetic Research (1997) Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. J Clin Oncol 15:124-130
12. The Italian Group for Antiemetic Research (1997) Delayed emesis induced by moderately emetogenic chemotherapy: do we need to treat all patients? Ann Oncol 8:561-567
13. The Italian Group for Antiemetic Research (2000) Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy. N Engl J Med 342:1554-1549